29 records – page 1 of 2.

Select Title Policy Type Year
EspAddText
EspRemoveText
Health Canada consultation on proposed vaping products promotion regulations Response to consultation 2020
EspAddText
EspRemoveText
Health Canada consultation on vaping products labelling and packaging regulations Response to consultation 2019
EspAddText
EspRemoveText
Health Canada consultation on potential market for cannabis health products that would not require practitioner oversight Response to consultation 2019
EspAddText
EspRemoveText
Health Canada consultation on reducing youth access and appeal of vaping products Response to consultation 2019
EspAddText
EspRemoveText
Health Canada consultation on the impact of vaping products advertising on youth and non-users of tobacco products Response to consultation 2019
EspAddText
EspRemoveText
Health Canada consultation on edible cannabis, extracts & topicals Response to consultation 2019
EspAddText
EspRemoveText
Health Canada’s consultation on new health-related labelling for tobacco products Response to consultation 2018
EspAddText
EspRemoveText
Health Canada consultation on Canadian drugs and substances strategy Response to consultation 2018
EspAddText
EspRemoveText
Implementation of National Pharmacare Response to consultation 2018
EspAddText
EspRemoveText
Health Canada consultation on tobacco products regulations (plain and standardized appearance) Response to consultation 2018
EspAddText
EspRemoveText
Health Canada consultation on regulatory amendments regarding tramadol Response to consultation 2018
EspAddText
EspRemoveText
Health Canada consultation on restriction of marketing and advertising of opioids Response to consultation 2018
EspAddText
EspRemoveText
Consultation on proposed front-of-package labelling Response to consultation 2018
EspAddText
EspRemoveText
Proposed approach to the regulation of cannabis Response to consultation 2018
EspAddText
EspRemoveText
Excise duty framework for cannabis products Response to consultation 2017
EspAddText
EspRemoveText
Non-prescription availability of low-dose codeine products Response to consultation 2017
EspAddText
EspRemoveText
CMA response to patented medicines regulations consultations Response to consultation 2017
EspAddText
EspRemoveText
Consultation on the renewal of Federal Tobacco Control Strategy Response to consultation 2017
EspAddText
EspRemoveText
Front-of-package labelling consultation Response to consultation 2016
EspAddText
EspRemoveText
Regulation of Self-Care Products in Canada Response to consultation 2016

29 records – page 1 of 2.